Home LiteratureArticle Details
PMID: 22286307 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.

Nature medicine ·Vol. 18 ·No. 2 ·2012-01-29 ·Pages 274-80

Wilkinson TM, Li CK, Chui CS, Huang AK, Perkins M, Liebner JC, Lambkin-Williams R, Gilbert A, Oxford J, Nicholas B, Staples KJ, Dong T, Douek DC, McMichael AJ, Xu XN

Abstract

Protective immunity against influenza virus infection is mediated by neutralizing antibodies, but the precise role of T cells in human influenza immunity is uncertain. We conducted influenza infection studies in healthy volunteers with no detectable antibodies to the challenge viruses H3N2 or H1N1. We mapped T cell responses to influenza before and during infection. We found a large increase in influenza-specific T cell responses by day 7, when virus was completely cleared from nasal samples and serum antibodies were still undetectable. Preexisting CD4+, but not CD8+, T cells responding to influenza internal proteins were associated with lower virus shedding and less severe illness. These CD4+ cells also responded to pandemic H1N1 (A/CA/07/2009) peptides and showed evidence of cytotoxic activity. These cells are an important statistical correlate of homotypic and heterotypic response and may limit severity of influenza infection by new strains in the absence of specific antibody responses. Our results provide information that may aid the design of future vaccines against emerging influenza strains.

MeSH Terms
Adolescent Adult Antibodies, Viral/blood,immunology CD4-Positive T-Lymphocytes/immunology CD8-Positive T-Lymphocytes/immunology Female Humans Immunity, Cellular/immunology Immunity, Humoral Influenza A Virus, H1N1 Subtype/immunology Influenza A Virus, H3N2 Subtype/immunology Influenza, Human/immunology,virology Male Middle Aged Severity of Illness Index Time Factors Virus Shedding/immunology Young Adult
Chemicals
Antibodies, Viral
Authors & Affiliations
15 authors, click to expand affiliations / ORCID
Wilkinson Tom M
Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Li Chris K F
Chui Cecilia S C
Huang Arthur K Y
Perkins Molly
Liebner Julia C
Lambkin-Williams Rob
Gilbert Anthony
Oxford John
Nicholas Ben
Staples Karl J
Dong Tao
Douek Daniel C
McMichael Andrew J
Xu Xiao-Ning
References (41)
41 references, click to expand
  1. Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites.
    J Virol. 1983 Oct;48(1):52-60 PMID: 6193288
  2. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.
    J Virol. 1996 Sep;70(9):5799-806 PMID: 8709196
  3. Characterization of CD4(+) CTLs ex vivo.
    J Immunol. 2002 Jun 1;168(11):5954-8 PMID: 12023402
  4. Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus.
    J Immunol. 2008 Feb 1;180(3):1758-68 PMID: 18209073
  5. Influenza vaccine--outmaneuvering antigenic shift and drift.
    N Engl J Med. 2004 Jan 15;350(3):218-20 PMID: 14724300
  6. T cell responses to whole SARS coronavirus in humans.
    J Immunol. 2008 Oct 15;181(8):5490-500 PMID: 18832706
  7. Cytotoxic T-cell immunity to influenza.
    N Engl J Med. 1983 Jul 7;309(1):13-7 PMID: 6602294
  8. Surveillance and impact of influenza in Europe. Groupe Régional d'Observation de la Grippe and European Influenza Surveillance Scheme.
    Vaccine. 1999 Jul 30;17 Suppl 1:S30-41 PMID: 10471178
  9. Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation.
    J Exp Med. 2006 Dec 25;203(13):2865-77 PMID: 17158960
  10. Hallmarks of CD4 T cell immunity against influenza.
    J Intern Med. 2011 May;269(5):507-18 PMID: 21362069
  11. Cytotoxic human CD4(+) T cells.
    Curr Opin Immunol. 2008 Jun;20(3):339-43 PMID: 18440213
  12. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus.
    Nature. 2006 Oct 5;443(7111):578-81 PMID: 17006449
  13. Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus.
    J Virol. 2010 Apr;84(7):3312-9 PMID: 20071564
  14. CD8+ T cells clear influenza virus by perforin or Fas-dependent processes.
    J Immunol. 1997 Dec 1;159(11):5197-200 PMID: 9548456
  15. Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus.
    J Immunol. 2010 Nov 1;185(9):4998-5002 PMID: 20889549
  16. Intraseasonal dynamics and dominant sequences in H3N2 influenza.
    PLoS One. 2010 Jan 01;5(1):e8544 PMID: 20049091
  17. An overview of serum antibody responses to influenza virus antigens.
    Dev Biol (Basel). 2003;115:25-30 PMID: 15088772
  18. Identification of T-cell epitopes using ELISpot and peptide pool arrays.
    Methods Mol Med. 2004;94:121-32 PMID: 14959826
  19. Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study.
    PLoS Med. 2011 Jun;8(6):e1000442 PMID: 21713000
  20. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009.
    N Engl J Med. 2009 Jun 18;360(25):2616-25 PMID: 19423871
  21. Correlates of protection: novel generations of influenza vaccines.
    Vaccine. 2008 Sep 12;26 Suppl 4:D41-4 PMID: 19230158
  22. A question of self-preservation: immunopathology in influenza virus infection.
    Immunol Cell Biol. 2007 Feb-Mar;85(2):85-92 PMID: 17213831
  23. Emerging infections: pandemic influenza.
    Epidemiol Rev. 1996;18(1):64-76 PMID: 8877331
  24. Would you volunteer to be quarantined and infected with influenza virus?
    Expert Rev Anti Infect Ther. 2005 Feb;3(1):1-2 PMID: 15757450
  25. Plaque formation with influenza viruses in dog kidney cells.
    J Gen Virol. 1976 Oct;33(1):143-5 PMID: 185324
  26. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10.
    Nat Med. 2009 Mar;15(3):277-84 PMID: 19234462
  27. Killer T cells in influenza.
    Pharmacol Ther. 2008 Nov;120(2):186-96 PMID: 18801385
  28. Reassortment between human A(H3N2) viruses is an important evolutionary mechanism.
    Vaccine. 2006 Nov 10;24(44-46):6683-90 PMID: 17030498
  29. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses.
    J Exp Med. 1998 Dec 21;188(12):2199-204 PMID: 9858506
  30. Clinical and laboratory diagnosis of influenza virus infections.
    Am J Manag Care. 2000 Mar;6(5 Suppl):S265-75 PMID: 10977473
  31. CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help.
    Nature. 2009 Nov 26;462(7272):510-3 PMID: 19898495
  32. Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection.
    J Exp Med. 2007 Apr 16;204(4):941-9 PMID: 17420267
  33. Helping the CD8(+) T-cell response.
    Nat Rev Immunol. 2004 Aug;4(8):595-602 PMID: 15286726
  34. Error thresholds and the constraints to RNA virus evolution.
    Trends Microbiol. 2003 Dec;11(12):543-6 PMID: 14659685
  35. The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment.
    Chest. 2010 Apr;137(4):759-68 PMID: 20061398
  36. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals.
    J Clin Invest. 2008 Oct;118(10):3478-90 PMID: 18802496
  37. Memory T-cell response to rotavirus detected with a gamma interferon enzyme-linked immunospot assay.
    J Virol. 2005 May;79(9):5684-94 PMID: 15827183
  38. Safety and efficacy of live attenuated, cold-adapted, influenza vaccine-trivalent.
    Immunol Allergy Clin North Am. 2003 Nov;23(4):745-67 PMID: 14753390
  39. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.
    Vaccine. 2007 Jan 8;25(4):612-20 PMID: 17005299
  40. The origins of pandemic influenza--lessons from the 1918 virus.
    N Engl J Med. 2005 Nov 24;353(21):2209-11 PMID: 16306515
  41. Epidemiology and virology of influenza illness. Based on a presentation by Arnold S. Monto, MD.
    Am J Manag Care. 2000 Mar;6(5 Suppl):S255-64 PMID: 10977472
Article Info
Journal
Nature medicine
Abbr.
Nat Med
ISSN
1546-170X
Published
2012-01-29
Epub
2012-00-29
Pages
274-80
Language
English
Region
United States
NLM ID
9502015
Subset
IM
Grants
Medical Research Council · G0600520 · United Kingdom
Medical Research Council · MC_U137884177 · United Kingdom
Medical Research Council · G1001047 · United Kingdom
Medical Research Council · MC_U137881015 · United Kingdom
Medical Research Council · G1001046 · United Kingdom
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]